Steps Toward Safe Cell Therapy Using Induced Pluripotent …

Posted: November 10, 2016 at 2:41 pm

Hideyuki Okano

From the Departments of Physiology (H.O., K.Y., Y.O., O.T., S.N., K.M.) and Orthopedic Surgery (M.N., O.T., S.N.) and Kanrinmaru Project (K.Y., Y.O.), School of Medicine, Keio University, Tokyo, Japan; Department of Pathology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan (E.I.); Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan (S.Y.); and Genomic Science Laboratory, Dainippon Sumitomo Pharma, Osaka, Japan (K.Y.).

Masaya Nakamura

From the Departments of Physiology (H.O., K.Y., Y.O., O.T., S.N., K.M.) and Orthopedic Surgery (M.N., O.T., S.N.) and Kanrinmaru Project (K.Y., Y.O.), School of Medicine, Keio University, Tokyo, Japan; Department of Pathology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan (E.I.); Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan (S.Y.); and Genomic Science Laboratory, Dainippon Sumitomo Pharma, Osaka, Japan (K.Y.).

Kenji Yoshida

From the Departments of Physiology (H.O., K.Y., Y.O., O.T., S.N., K.M.) and Orthopedic Surgery (M.N., O.T., S.N.) and Kanrinmaru Project (K.Y., Y.O.), School of Medicine, Keio University, Tokyo, Japan; Department of Pathology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan (E.I.); Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan (S.Y.); and Genomic Science Laboratory, Dainippon Sumitomo Pharma, Osaka, Japan (K.Y.).

Yohei Okada

From the Departments of Physiology (H.O., K.Y., Y.O., O.T., S.N., K.M.) and Orthopedic Surgery (M.N., O.T., S.N.) and Kanrinmaru Project (K.Y., Y.O.), School of Medicine, Keio University, Tokyo, Japan; Department of Pathology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan (E.I.); Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan (S.Y.); and Genomic Science Laboratory, Dainippon Sumitomo Pharma, Osaka, Japan (K.Y.).

Osahiko Tsuji

From the Departments of Physiology (H.O., K.Y., Y.O., O.T., S.N., K.M.) and Orthopedic Surgery (M.N., O.T., S.N.) and Kanrinmaru Project (K.Y., Y.O.), School of Medicine, Keio University, Tokyo, Japan; Department of Pathology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan (E.I.); Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan (S.Y.); and Genomic Science Laboratory, Dainippon Sumitomo Pharma, Osaka, Japan (K.Y.).

Satoshi Nori

From the Departments of Physiology (H.O., K.Y., Y.O., O.T., S.N., K.M.) and Orthopedic Surgery (M.N., O.T., S.N.) and Kanrinmaru Project (K.Y., Y.O.), School of Medicine, Keio University, Tokyo, Japan; Department of Pathology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan (E.I.); Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan (S.Y.); and Genomic Science Laboratory, Dainippon Sumitomo Pharma, Osaka, Japan (K.Y.).

Eiji Ikeda

From the Departments of Physiology (H.O., K.Y., Y.O., O.T., S.N., K.M.) and Orthopedic Surgery (M.N., O.T., S.N.) and Kanrinmaru Project (K.Y., Y.O.), School of Medicine, Keio University, Tokyo, Japan; Department of Pathology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan (E.I.); Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan (S.Y.); and Genomic Science Laboratory, Dainippon Sumitomo Pharma, Osaka, Japan (K.Y.).

Shinya Yamanaka

From the Departments of Physiology (H.O., K.Y., Y.O., O.T., S.N., K.M.) and Orthopedic Surgery (M.N., O.T., S.N.) and Kanrinmaru Project (K.Y., Y.O.), School of Medicine, Keio University, Tokyo, Japan; Department of Pathology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan (E.I.); Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan (S.Y.); and Genomic Science Laboratory, Dainippon Sumitomo Pharma, Osaka, Japan (K.Y.).

Kyoko Miura

From the Departments of Physiology (H.O., K.Y., Y.O., O.T., S.N., K.M.) and Orthopedic Surgery (M.N., O.T., S.N.) and Kanrinmaru Project (K.Y., Y.O.), School of Medicine, Keio University, Tokyo, Japan; Department of Pathology, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan (E.I.); Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan (S.Y.); and Genomic Science Laboratory, Dainippon Sumitomo Pharma, Osaka, Japan (K.Y.).

More:
Steps Toward Safe Cell Therapy Using Induced Pluripotent ...

Related Posts

Comments are closed.

Archives